Varaico: Literature-Extracted Genetic Variants

Gene:CYP21A2
Variant:p.W22*
Back to variants list

CYP21A2

NM_000500.9:p.W22*

Associated Papers

Genetic characterization and screening of congenital adrenal hyperplasia by long-read sequencing in a cohort of 21,239 newborns.

Liang D et al.

Genome Medicine, 2025

Chimeric CYP21A1P/CYP21A2 Genes in 21-Hydroxylase Deficiency Detected by Long-Read Sequencing and Phenotypes Correlation.

Zhang X et al.

The Journal of Clinical Endocrinology and Metabolism, 2025

Lessons Learned from 17 Years of Multidisciplinary Care for Differences of Sex Development Patients at a Single Indonesian Center.

Faradz SMH et al.

Sexual Development : Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation, 2023

EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency.

Baumgartner-Parzer S et al.

European Journal of Human Genetics : Ejhg, 2020

A Novel Nonsense Mutation c.374C>G in CYP21A2 Gene of a Vietnamese Patient with Congenital Adrenal Hyperplasia.

Vu CD et al.

Advances in Experimental Medicine and Biology, 2020

Congenital Adrenal Hyperplasia (CAH) due to 21-Hydroxylase Deficiency: A Comprehensive Focus on 233 Pathogenic Variants of CYP21A2 Gene.

Concolino P et al.

Molecular Diagnosis & Therapy, 2018

CYP21A2 mutation update: Comprehensive analysis of databases and published genetic variants.

Simonetti L et al.

Human Mutation, 2018

Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women.

Carmina E et al.

Human Reproduction Update, 2017

Structure-based activity prediction of CYP21A2 stability variants: A survey of available gene variations.

Bruque CD et al.

Scientific Reports, 2016

27966633 (PubMed )
Supplement: srep39082-s1.pdf

The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene.

Livadas S et al.

Clinical Endocrinology, 2015

One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study.

Gidlöf S et al.

The Lancet. Diabetes & Endocrinology, 2013

Infertility reversed by glucocorticoids and full-term pregnancy in a couple with previously undiagnosed nonclassic congenital adrenal hyperplasia.

Trakakis E et al.

Fertility and Sterility, 2011

Salt-wasting congenital adrenal hyperplasia: genotypical peculiarities in a Sicilian ethnic group.

Wasniewska M et al.

Journal of Endocrinological Investigation, 2008

Novel nonsense mutation (W22X) in CYP21A2 gene causing salt-wasting congenital adrenal hyperplasia in a compound heterozygous girl.

Di Pasquale L et al.

Journal of Endocrinological Investigation, 2007

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

White PC et al.

Endocrine Reviews, 2000

Steroid 21-hydroxylase deficiency: mutational spectrum in Denmark, three novel mutations, and in vitro expression analysis.

Ohlsson G et al.

Human Mutation, 1999

An update on the molecular genetics of congenital adrenal hyperplasia: diagnostic and therapeutic aspects.

Wedell A

Journal of Pediatric Endocrinology & Metabolism : Jpem, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."